Contrast Enhanced Ultrasound Evaluation of Brain Perfusion in Neonatal Post-Hemorrhagic Hydrocephalus

Trial Profile

Contrast Enhanced Ultrasound Evaluation of Brain Perfusion in Neonatal Post-Hemorrhagic Hydrocephalus

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 29 Jan 2018

At a glance

  • Drugs Sulfur hexafluoride (Primary)
  • Indications Hydrocephalus
  • Focus Pharmacokinetics
  • Most Recent Events

    • 22 Jan 2018 Status changed from not yet recruiting to withdrawn prior to enrolment as PI is leaving the institution
    • 15 Mar 2017 Planned initiation date changed from 1 Mar 2017 to 1 Apr 2017.
    • 02 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top